Close Menu

stock offering

Arrowhead Research this week announced that it will sell 5.5 million shares of its common stock at $18.95 apiece for gross proceeds of $104 million.

Correction: The story has been updated to include the correct net proceed amount from the sale. NEW YORK (GenomeWeb News) – Fluidigm said after the close of the market on Tuesday it has closed on the sale of about $201.3 million of senior convertible notes.

NEW YORK (GenomeWeb News) – Cepheid said after the close of the market on Tuesday it has increased the amount of convertible senior notes it is offering and has priced them.

NEW YORK (GenomeWeb News) – Cepheid said after the close of the market on Monday that it plans to offer $250 million aggregate principal amount of convertible senior notes due 2021.

NEW YORK (GenomeWeb News) – NanoString Technologies has priced the follow-on public offering of its common stock at $18.50 per share.

NEW YORK (GenomeWeb News) – Atossa Genetics today priced its public offering of 5.8 million units at $2.40 per unit, saying it anticipates raising $14 million in gross proceeds.

NEW YORK (GenomeWeb News) – NanoString Technologies said after the close of the market Tuesday that it has launched a follow-on public offering of $55 million of common stock.

NEW YORK (GenomeWeb News) – CombiMatrix today said it has closed its public offering of 12,000 units of Series D convertible preferred stock and warrants, raising $12 million in gross proceeds.

NEW YORK (GenomeWeb News) – CombiMatrix increased the number of securities it intends to sell in a public offering, the company said today in a document filed with the US Securities and Exchange Commission.

NEW YORK (GenomeWeb News) – Response Genetics has launched a public offering of nearly 4.5 million shares of its common stock at $1.20 per share.

Pages

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.